1. Home
  2. ACTU vs STKS Comparison

ACTU vs STKS Comparison

Compare ACTU & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • STKS
  • Stock Information
  • Founded
  • ACTU 2015
  • STKS 2004
  • Country
  • ACTU United States
  • STKS United States
  • Employees
  • ACTU N/A
  • STKS N/A
  • Industry
  • ACTU
  • STKS Restaurants
  • Sector
  • ACTU
  • STKS Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • STKS Nasdaq
  • Market Cap
  • ACTU 135.0M
  • STKS 109.7M
  • IPO Year
  • ACTU 2024
  • STKS N/A
  • Fundamental
  • Price
  • ACTU $7.26
  • STKS $3.33
  • Analyst Decision
  • ACTU Strong Buy
  • STKS Hold
  • Analyst Count
  • ACTU 1
  • STKS 3
  • Target Price
  • ACTU $20.00
  • STKS $4.83
  • AVG Volume (30 Days)
  • ACTU 170.2K
  • STKS 341.5K
  • Earning Date
  • ACTU 09-23-2025
  • STKS 08-05-2025
  • Dividend Yield
  • ACTU N/A
  • STKS N/A
  • EPS Growth
  • ACTU N/A
  • STKS N/A
  • EPS
  • ACTU N/A
  • STKS N/A
  • Revenue
  • ACTU N/A
  • STKS $799,478,000.00
  • Revenue This Year
  • ACTU N/A
  • STKS $26.92
  • Revenue Next Year
  • ACTU N/A
  • STKS $5.39
  • P/E Ratio
  • ACTU N/A
  • STKS N/A
  • Revenue Growth
  • ACTU N/A
  • STKS 138.50
  • 52 Week Low
  • ACTU $5.47
  • STKS $2.37
  • 52 Week High
  • ACTU $11.99
  • STKS $5.42
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • STKS 37.71
  • Support Level
  • ACTU N/A
  • STKS $3.31
  • Resistance Level
  • ACTU N/A
  • STKS $4.12
  • Average True Range (ATR)
  • ACTU 0.00
  • STKS 0.32
  • MACD
  • ACTU 0.00
  • STKS -0.14
  • Stochastic Oscillator
  • ACTU 0.00
  • STKS 5.52

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

Share on Social Networks: